Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02247947

Enrollment

Registered

2014-09-25

Start date

2014-09-30

Completion date

2020-11-01

Last updated

2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Keywords

CPR

Brief summary

Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Detailed description

Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* cardiac arrest

Exclusion criteria

* trauma

Design outcomes

Primary

Measure	Time frame
death at day 20	day 20

Countries

Germany

Outcome results